U
VXRT

UBS’s Vaxart VXRT Stock Holding History

UBS’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$4K Buy
+155
New +$4.45K ﹤0.01% 9654
2014
Q2 		– Sell
-7,657
Closed -$515K – 10864
2014
Q1 		$515K Buy
7,657
+7,618
+19,533% +$471K ﹤0.01% 4198
2013
Q4 		$2K Sell
39
-523
-93% -$23K ﹤0.01% 10069
2013
Q3 		$26K Buy
562
+458
+440% +$19.9K ﹤0.01% 7724
2013
Q2 		$4K Buy
+104
New +$4.32K ﹤0.01% 9441

Other funds holding VXRT

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS's VXRT Position: Q3 2014 in Review

UBS opened a new position in Vaxart (VXRT) in Q3 2014: 155 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #9654 among its holdings. This is a return to the name: UBS previously reported a position in VXRT as recently as Q1 2014.

UBS first reported a position in VXRT in Q2 2013 and has held it in 5 quarters since. The position peaked at $515K in Q1 2014. 49 funds tracked by Wall St. Rank hold VXRT as of Q3 2014.

  • UBS held 155 shares of Vaxart worth $4K as of Q3 2014.
  • Vaxart was a new UBS position in Q3 2014.
  • Vaxart made up ﹤0.01% of UBS's portfolio in Q3 2014, its #9654 holding.
  • UBS first reported a position in Vaxart in Q2 2013 and has held it in 5 quarters since.
  • UBS's Vaxart position peaked at $515K in Q1 2014.
  • 49 funds tracked by Wall St. Rank held Vaxart as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.